$3.940
-0.069 (-1.75%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de CNSP por análisis de gráficos similares
Alphio's CNSP stock price prediction model matches the current CNS Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.97 (+0.88%). The 1-week path is $4.07 (+3.40%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de CNS Pharmaceuticals Inc?
CNS Pharmaceuticals is not a good buy right now due to its significant financial losses and poor technical indicators. The current price is $3.94, with an RSI of 29.263 indicating oversold conditions. The company reported a net loss of approximately $4.937 million in Q1 2026, which is a 14.7% increase from the previous year's loss. Additionally, the stock has decreased by 39.29% over the past year, reflecting ongoing financial struggles and lack of revenue, which raises concerns about its long-term viability.
CNSP cerró en $3.94 el Friday, tras bajar -1.75%
CNS Pharmaceuticals Inc (CNSP) last closed at $3.9400001, losing -1.75%. These facts feed the 1-day and 1-week CNSP price prediction above.
Factores de la previsión
Los factores de la previsión de CNS Pharmaceuticals Inc (CNSP) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de CNSP, ordenadas por similitud.
Análisis de estacionalidad de CNSP
Historically the probability of a positive November return for CNSP is 0.00%. January offers the highest probability of a positive month at 36.07%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de CNSP
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $0.63 | $0.75 | $0.86 | -80.99% |
| Dec 2026 | $0.77 | $0.91 | $0.98 | -76.97% |
En 2026, se proyecta que CNS Pharmaceuticals Inc (CNSP) oscile entre $0.63 y $0.98.
Previsión mensual de CNS Pharmaceuticals Inc para 2026
En Nov de 2026, se proyecta que CNS Pharmaceuticals Inc promedie $0.75, con un mínimo de $0.63 y un máximo de $0.86.
En Dec de 2026, se proyecta que CNS Pharmaceuticals Inc promedie $0.91, con un mínimo de $0.77 y un máximo de $0.98.
Artículos relacionados
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.